Why Johnson & Johnson Stock Got Tossed by the Market Today
The latest earnings season has begun, and the latest quarterly results from some of our economy's largest companies are starting to come in.
Tuesday morning, it was healthcare mainstay Johnson & Johnson's (NYSE: JNJ) turn in the spotlight, and investors weren't all that satisfied with the performance. In the wake of the company's first-quarter earnings report, the stock traded down by over 2%. That was a steeper fall than the 0.2% decline of the S&P 500 index on the day.
In its first quarter, Johnson & Johnson earned $21.38 billion in sales, which was more than 2% higher on a year-over-year basis. Non-GAAP (adjusted) net income also edged higher, rising by nearly 4% to $6.58 billion, or $2.71 per share.
Source Fool.com
